Another drawback of these NLRP3 inhibitors is that prolonged suppression of NLRP3 activity may impair physiological immune responses, thereby increasing vulnerability to infections and diminishing normal tissue repair processes, which highlights an important long-term safety concern [172]. This evidence concerns the gene NLRP3 and infection.